2025’s Top Cannabis Strains: Blue Dream Reigns Supreme Amidst Shifting Trends

Nationwide Cannabis Sales Reveal 2025’s Hottest Strains The U.S. cannabis market continues its robust expansion in 2025. Sales are projected to reach significant figures. Consumer preferences drive constant innovation. Certain strains, however, maintain enduring popularity. Others are rapidly trending nationwide. This news covers the top-selling cannabis strains of the year. It also explores key market…

Read More

Trump Reclassifies Marijuana to Schedule III, Ushering in New Era for Research and Industry

President Donald Trump signed a landmark executive order on December 18, 2025. This order reclassifies marijuana. It moves the drug from Schedule I to Schedule III. This marks a historic shift in federal drug policy. It is the biggest change since 1970. This move acknowledges marijuana’s accepted medical uses. It also recognizes its lower abuse…

Read More

Trump Reclassifies Marijuana to Schedule III, Easing Regulations and Igniting Industry Hopes

President Donald Trump signed a pivotal executive order. This happened on December 18, 2025. The order eases federal marijuana regulations. It reclassifies cannabis from Schedule I. It moves to Schedule III under the Controlled Substances Act. This marks a major policy shift. It is one of the most significant in decades. A Historic Reclassification The…

Read More

Trump Executive Order Reschedules Cannabis to Schedule III, Expands Medicare CBD Access

President Donald Trump signed a significant executive order on December 18, 2025. This order makes major changes to federal cannabis policy. It directs the Justice Department to expedite marijuana’s rescheduling. Marijuana moves from Schedule I to Schedule III of the Controlled Substances Act. This is a historic shift. It eases restrictions on medical research. It…

Read More